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Abstract
Chronic inflammation is associated with disease risk and mortality in the general population. Soluble urokinase plasminogen activator receptor
(suPAR) is a stable marker of chronic inflammation, and a higher serum-concentration of suPAR is found in individuals with an unhealthy
lifestyle such as smoking. This article investigates the association between suPAR and dietary quality measured with the dietary quality score
(DQS). The DQS is an index of the overall quality of an individual’s dietary habits assessed through a self-administered FFQ. Furthermore, this
article investigates the association of both suPAR and the DQS with CVD risk and mortality in the general Danish population. We analysed
5347 individuals aged 30–60 years from the Danish Inter99 study cohort. Multiple linear regression analyses showed a linear inverse
association between the DQS and suPAR (P= 0·0005). Cox regression analyses showed an 18 (95% CI 9, 26)% increase in the risk of death
from any cause with each 1 ng/ml increase in suPAR. We found no significant association between the DQS and the mortality (hazard ratio:
1·16, 95% CI 0·79, 1·69). All analyses were adjusted for demographics and lifestyle factors. The association between the DQS and suPAR on
the one hand and suPAR and mortality on the other supports the argument that low dietary quality may constitute a health risk through its
influence on chronic inflammation. Future research should examine whether suPAR is modifiable through changes in dietary habits.
Key words: Inflammation: Dietary quality: Soluble urokinase plasminogen activator receptor: Biomarkers: Epidemiological
studies
Systemic low-grade (or chronic) inflammation is widely recog-
nised as a modifiable risk factor for disease and premature
death(1,2). Knowledge about how lifestyle affects the inflam-
matory status is therefore of importance for health professionals
if they are to reduce the risk of disease.
Soluble urokinase plasminogen activator receptor (suPAR) has
been established as a stable marker of chronic inflammation and as
a predictor of disease and mortality in the general population(3–5).
suPAR has also been shown to predict disease severity and mor-
tality in acutely admitted medical patients(6,7). It has previously
been shown that the serum suPAR concentration in the general
population is associated with lifestyle habits including alcohol (U
shaped) and diet (linear)(8,9). The relationship between diet and
inflammation is supported by several studies that show associations
between healthy dietary patterns and lower serum concentrations
of high-sensitivity C-reactive protein and IL-6(10–13). Dietary habits
are an important risk factor for CVD and overall mortality(14–18).
This relates to dietary components as well as overall dietary quality.
A healthy diet is recognised as a diet high in fruits, vegetables, fish
and fibre and low in saturated animal fat. About a decade ago, it
was noted that the study of dietary patterns is important because
such patterns express the complex nature of a composite diet and
the actions and interactions of the diet in the body more accurately
than the study of single nutrients is able to(18).
Though a relationship between overall dietary quality and
suPAR has been shown earlier(9), a specific pattern for this
relationship has not been established. The aim of this study was
to investigate the relationship between dietary quality and
suPAR in detail as well as to investigate the association of each
of these factors with mortality and future IHD and stroke. This
investigation was carried out using a large random sample of
the general Danish population followed for 12 years.
Methods
Study population
This study includes participants from the Inter99 study. Inter99
was a randomised intervention study investigating the effect of
Abbreviations: DQS, dietary quality score, suPAR, soluble urokinase plasminogen activator receptor.
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individual lifestyle counselling and group-based lifestyle edu-
cation on the risk of CVD. Detailed design and results are
presented elsewhere(19,20). In short, the Inter99 cohort com-
prised 61 301 randomly selected individuals aged 30–60 years
from the southwestern area of the Capital Region of Denmark.
Of these, 13 016 (21·2%) were randomly assigned to the inter-
vention group and 6784 (52·1%) were examined at baseline in
1999–2001. We analysed the 5347 (78·8%) of the examined
participants who had both a suPAR measurement and a dietary
quality score (DQS) available (Fig. 1). Characteristics of exclu-
ded participants are shown in online Supplementary Tables S1
and S2.
Data collection
The collection of data is described in detail elsewhere(19,20). In
short, the participants answered a detailed questionnaire about
demographics, lifestyle habits and healthcare contacts and
underwent a physical examination at baseline. Fasting blood
samples were drawn from all participants. Total cholesterol was
measured instantly and the blood samples were stored at –80°C
for later analysis of the remaining biomarkers(19,20). Efficient
matching of collected data with the individual study participant
was achieved through linking of the data to personal id num-
bers (Central Person Registry (CPR)-numbers)(21).
Demographics. Data on sex and age were extracted from the
Danish Civil Registration System using each participant’s CPR
number. Socio-economic status was stratified into three groups
based on the length of vocational training/tertiary education:
<2 years (‘low’), 2–4 years (‘average’) and >4 years (‘high’).
Lifestyle habits. Lifestyle habits were self-reported by ques-
tionnaire. Dietary intake was measured using a validated self-
administered forty-eight-item FFQ including questions about
the intake of fruit, vegetables, fish and fat. From this, the DQS
was calculated. The DQS was developed on the basis of Danish
national dietary guidelines in 2007 by Toft et al.(22) using a
forty-eight-item FFQ and validated against a 198-item FFQ. The
DQS divides individuals into one of nine categories based on
questions regarding the intake of fruits, boiled vegetables, raw
vegetables, vegetable or vegetarian dishes, fish for lunch and
fish for dinner, fat as spread and fat used at preparation. The
categories of the DQS range from non-prudent (group 1) to
prudent (group 9) dietary habits(22). For fruit, vegetables and
fish, the score was based on quantity; but for fat, points were
assigned based on the type of fat. Baseline smoking habits were
categorised as daily smoker (min. 1 cigarette/g tobacco per d),
occasional smoker, former smoker or never smoker. Weekly
alcohol consumption (in units of 12 g alcohol/week) was
divided into four groups based on national health recommen-
dations in 1999: abstinent (0 units/week), within recommen-
dations (1–14 units/week for women, 1–21 units/week for
men), borderline consumption (14–35 units/week for women,
21–35 units/week for men) and overuse (more than 35 units/
week for all). Physical activity was defined as the sum of leisure
time physical activity and the amount of the time spent on
transportation to and from work, consisting of walking, running
or biking(23). The sum was converted into minutes a week,
using a 5-d working week, and was divided into four groups:
0–112·5, 142·5–225, 255–420 and 450–720 min/week.
Recording of endpoints. Data on endpoints were extracted
from Danish registries using the participants’ unique CPR
number. Deaths were extracted from the Danish Civil Regis-
tration System(21), hospital admissions from the National Patient
Registry(24) and causes of death from the National Registry of
Causes of Death(20,25). IHD was defined as the International
Classification of Diseases (ICD)-8 codes 410–414 or ICD-10
codes I20–I25 or as relevant cardiac surgery (bypass, recanali-
sation or reconstruction of coronary arteries). Stroke included
both haemorrhagic and ischaemic stroke and was defined as
the ICD-8 codes 430–434 or 436 or ICD-10 codes I60–I64 or
I69(20).
Biomarker measurements. The baseline plasma samples were
collected in 1999–2001 and stored at –80°C until measurement
of suPAR, which took place in 2011. suPAR levels were deter-
mined using the suPARnostic sandwich ELISA (ViroGates
A/S)(9). One participant with a suPAR concentration above
22 ng/ml (upper limit of assay) was excluded from further
analyses. The concentration of total cholesterol, HDL-
cholesterol and TAG were determined on fresh unfrozen sam-
ples at baseline (1999–2001) by enzymatic techniques with the
Hitachi 912 System (Roche Diagnostics)(19). The concentration
of LDL-cholesterol was calculated by Friedewald’s equation(26).
Participants had their weight and height measured, and BMI
was calculated as weight (kg)/height (m)2(19).
Total cohort
(n 61 301)
Randomised to
intervention
(n 13 016)
Examined at
baseline
(n 6784)
Analysed
(n 5347)
– suPAR not measured at
baseline (n 1246)
– suPAR measurement above
upper limit of assay (n 1)
– Subjects missing either a
Dietary Quality Score or a
suPAR measurement at
baseline (n 190)
Fig. 1. Flowchart of study population. suPAR, soluble urokinase plasminogen
activator receptor.
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Ethics
All participants provided written informed consent before tak-
ing part in the study. The study was approved by the local
ethics committee (KA 98 155), by the Danish Data Protection
Agency, and it was conducted in accordance with the
Declaration of Helsinki. The study is registered with
ClinicalTrials.gov (NCT00289237).
Statistics
Baseline characteristics were described by mean value, stan-
dard deviation and range for continuous variables and number
of observations and percentages for categorical variables.
To guide the analysis plan, we created a directed acyclic
graph (Fig. 2)(27). The graph contains all investigated factors,
and arrows indicate a causal relation. This visualisation allowed
for a ready identification of potential confounders. The causal
pattern and adjustments for confounders enables the control for
unknown confounding by closing all ‘backdoors’ in the directed
acyclic graph(27). When assessing the total effect of diet on
endpoints, we did not adjust for intermediary factors to avoid
overadjustment biases and unnecessary adjustments(28). From
the directed acyclic graph, it is further visualised that adjusting
for suPAR in an analysis of the dietary effect on endpoints
provides an assessment of all effects of diet on endpoints that is
not mediated by suPAR.
In the univariate analyses, we used one-way ANOVA to test
the distributions of biomarkers (suPAR, total cholesterol, HDL-
cholesterol and BMI) in the groups of the DQS. We tested the
distributions of these biomarkers in the individual food groups
as well, if an association with the DQS was found. The adjusted
analyses were multiple linear regressions with log2-transformed
suPAR, total cholesterol, HDL-cholesterol and BMI modelled as
functions of sex, age, lifestyle factors (smoking habits, alcohol
intake and physical activity) and the DQS (reference was
DQS= group 5). In the adjusted analyses, we allowed for an
interaction between sex and age. In addition, the effect of the
DQS on biomarkers was modelled as a continuous variable, as
the DQS showed no departure from trend (P= 0·27–0·81).
Estimates were back transformed by (2β–1)× 100% and inter-
preted as percentage difference in biomarker concentration.
Data on endpoints are presented as mean follow-up time in
years, number and percentage of participants who reached the
specific endpoints, events per 1000 person years and, for IHD
and stroke, the case fatality rates. We analysed time to IHD, stroke
and death with cumulative incidence plots stratified by the DQS
(dichotomised into ‘unhealthy diet‘ (scores 1–3) and ‘inter-
mediate/healthy diet’ (scores 4–9)) and sex- and age-specific
(≤45 or >45 years) suPAR quartiles. For both IHD and stroke,
death was set as a competing endpoint. Log-rank tests were
carried out to determine whether the cumulative incidence was
different between the groups. Furthermore, time-to-event were
analysed by the Cox proportional hazards method to estimate
three effects: any total effect of DQS, any effect of DQS not going
through changes in suPAR concentration and any total effect of
suPAR. Thus, three models were devised for each endpoint:
(1) The total dietary effect with dichotomised DQS, sex, age
and lifestyle factors as explanatory variables.
(2) The suPAR-adjusted dietary effect with dichotomised
DQS, sex, age, lifestyle factors and suPAR concentration
as explanatory variables.
(3) The total suPAR effect with suPAR concentration, sex, age,
dichotomised DQS, lifestyle factors, total and HDL-cho-
lesterol, blood pressure, prevalent diabetes mellitus and
prevalent CVD as explanatory variables.
For all survival analyses, participants with prior IHD was
excluded from analyses with IHD as the endpoint. The same
approach was used for stroke. All Cox models were performed
Sex, age, and unmeasured confounding*
Dietary quality and other lifestyle factors†
Cholesterol, blood pressure, prevalent diabetes, and prevalent CVD
suPAR
Cardiovascular event‡
Mortality
Fig. 2. Directed acyclic graph showing the hypothesised causality between the investigated factors and confounders. The causality relations of the factors
are visualised by arrows. * Unmeasured confounders include genetic makeup and other known or unknown individual characteristics that affect behaviour and health.
† Other lifestyle factors include smoking habits, alcohol consumption and physical activity. ‡ Cardiovascular event includes IHD and stroke. suPAR, soluble urokinase
plasminogen activator receptor.
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as single failure-time analyses. Data were right censored at the
end of follow-up, and for IHD and stroke we used a censoring
variable with three levels: 0 (no event in the follow-up
period), 1 (event within the follow-up period) and 2 (death
within the follow-up period). For death, we used a censoring
variable with two levels: 0 (no event in the follow-up period)
and 1 (death within the follow-up period). Time to event was
measured from the date of enrolment into the study (between
March 1999 and January 2001), and follow-up in national
registries was carried out until 11th of July 2011. Time on study
in days was used as the underlying timescale. We tested the
potential interaction between age and diet and age and suPAR,
respectively; the estimates are shown in online Supplementary
Table S3.
To quantify the effect of missing values on the regression
results, we did the following modelling: we performed each
regression twice for each confounding variable containing
missing values (physical activity, alcohol consumption and
smoking status). First, we performed the regression excluding
the variable of interest. Then, we performed the same regres-
sion but excluding participants with a missing value in the
variable of interest. Last, we compared the estimates from the
two regressions.
R 3.2.3 (R Foundation) and SAS 9.4 (SAS Institute) were used
for statistical analyses. In the Cox regressions, the Efron
approximation was used to handle tied observations.
Results
Cohort characteristics
In total, 5347 participants (51·5% women, P= 0·03) were
included. Baseline characteristics are presented in Table 1.
Soluble urokinase plasminogen activator receptor and
dietary quality score
When suPAR concentrations were stratified according to the
DQS groups and tested with one-way ANOVA, we found a
significant difference in the means of the groups (Table 2;
P< 0·0001). When adjusted for sex, age and lifestyle factors
(smoking habits, alcohol intake and physical activity) in the
linear model, suPAR was associated with the DQS
(βgroup1= 10·0 (–1·3–22·6) %; βgroup9= –2·9 (–14·8–10·6) %;
reference= group 5; P= 0·0005; Fig. 3). The linear effect of
the DQS on suPAR was a 1·6 % decrease (95 % CI 1·0, 2·3 %,
P< 0·0001) in suPAR per one step increase in DQS. When
instead stratifying suPAR concentrations according to the
food groups comprising the DQS (fruit, vegetables, fish and
fat), we found a significantly different distribution of suPAR
values between the healthy, intermediate and unhealthy
group in each food group except in the ‘fish’ group
(Table 3).
Cholesterol, BMI and dietary quality score
HDL-cholesterol was distributed significantly different between
the groups of the DQS (Table 2; P< 0·0001). This was not the
case for total cholesterol (Table 2; P= 0·10) nor BMI (Table 2;
P= 0·27). When adjusted for sex, age and lifestyle factors,
borderline associations with the DQS were found for total
cholesterol (βgroup1= 2·4 (–3·7 to 8·8)%; βgroup9= –6·5 (–13·1 to
0·7)%; reference= group 5; P= 0·07; Fig. 3) and HDL-
cholesterol (βgroup1= 3·7 (–4·4 to 12·5)%; βgroup9= –0·3 (–9·6
to 9·9)%; reference= group 5; P= 0·07; Fig. 3). No association
was found with BMI (βgroup1= 1·9 (–3·4 to 7·5)%; βgroup9= 3·24
(–3·0 to 10·3)%; reference= group 5; P= 0·16; Fig. 3). The linear
Table 1. Characteristics of the study cohort at baseline
(Numbers, percentages and ranges; mean values and standard
deviations)
Variable (unit) n % Range
Age (years) 5347 29·7–61·3
Mean 45·9
SD 8·0
Sex 5347
Female 2754 51·5
Male 2593 48·5
suPAR (ng/ml) 5347 0·65–21·2
Mean 3·71
SD 1·52
Total cholesterol (mmol/l) 5345 2·30–12·2
Mean 5·52
SD 1·10
HDL-cholesterol (mmol/l) 5346 0·25–3·71
Mean 1·43
SD 0·40
LDL-cholesterol (mmol/l) 5280 0·80–7·90
Mean 3·50
SD 0·96
TAG (mmol/l) 5345 0·30–36·0
Mean 1·34
SD 1·11
Systolic blood pressure (mmHg) 5346 83–213
Mean 130
SD 17
Diastolic blood pressure (mmHg) 5345 30–140
Mean 82
SD 11
BMI (kg/m2) 5344 14·9–55·7
Mean 26·2
SD 4·6
Prevalent diabetes 303 5·7
Prevalent CVD 99 1·9
Smoking status* 5347
Daily smoker 1887 35·3
Occasional smoker 200 3·7
Former smoker 1341 25·1
Never smoker 1902 35·6
Alcohol consumption* 5347
Abstinent 519 9·7
Within recommendations 3814 71·4
Borderline 608 11·4
Overuse 203 3·8
Physical activity* 5347
0–112·5 min 644 12·0
142·5–225 min 1129 21·1
255–420 min 2630 49·2
450–720 min 635 11·9
Socio-economic status* 5347
Low 1090 20·4
Medium 3278 61·3
High 576 10·8
suPAR, soluble urokinase plasminogen activator receptor.
* Missing data are not shown.
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effect of the DQS was a 0·5% (95% CI 0·2, 0·9%, P= 0·007)
decrease in total cholesterol and a 0·7% (95% CI 0·2, 1·2%,
P= 0·0065) decrease in HDL-cholesterol per one step increase
in DQS. BMI showed no association with the continuous ver-
sion of the DQS. As none of the cardiovascular risk markers
were significantly associated with the categorical DQS in the
adjusted model, we did not examine the univariate distributions
of these markers in the food groups.
Dietary quality score, soluble urokinase plasminogen
activator receptor and risk of IHD, stroke and death
During 11·3 years of mean follow-up, 339 (6·3%) were diagnosed
with IHD (5·6/1000 person-years, case fatality rate=3·5%), 189
(3·5%) were diagnosed with stroke (3·1/1000 person-years, case
fatality rate=2·1%) and 215 (4·0%) had died (3·6/1000 person-
years). Fig. 4 shows cumulative incidence plots for IHD, stroke and
death according to dichotomised DQS (unhealthy v. average/
healthy) and sex- and age-specific suPAR quartiles. The DQS was
significantly associated with IHD and mortality but not with stroke
(Fig. 4(a)–(c)), whereas suPAR was significantly associated with
stroke and mortality (Fig. 4(e) and (f)) and borderline associated
with IHD (Fig. 4(d)). When adjusted for sex, age and lifestyle
factors, low dietary quality showed no significant association with
IHD risk, stroke risk or mortality (Table 4). Similar results were
found in the suPAR-adjusted model (Table 4). The total effect of
suPAR was a 13 (95% CI 2, 25)% increase in the risk of stroke and
an 18 (95% CI 9, 26)% increase in the risk of death from any cause
for each 1ng/ml increase in suPAR, while no association was
found between suPAR and IHD risk (Table 4).
Discussion
In this large cohort study of randomly selected individuals from
the general population, we showed that the serum concentra-
tion of the inflammatory biomarker suPAR was inversely asso-
ciated with the DQS. When following the participants for 12
years, a higher suPAR concentration was associated with greater
risk of stroke and higher mortality but not with IHD risk.
To compare suPAR to established biomarkers of CVD risk, we
examined the association of the DQS with total and HDL-
cholesterol and BMI. None of these cardiovascular risk markers
was associated with the DQS as a categorical variable adjusted
for sex, age and lifestyle factors (smoking habits, alcohol intake
and physical activity). When treated as a continuous variable,
the DQS was associated with total and HDL-cholesterol, indi-
cating that the dietary quality does affect plasma cholesterol
concentration. Toft et al.(22) has investigated the association of
the DQS with total and HDL-cholesterol and BMI in the same
cohort and found a significant trend toward lower total cho-
lesterol concentrations in subjects with higher DQS, but no
association between the DQS and HDL-cholesterol or BMI. The
difference between the findings by Toft et al. and our results
may be due to the adjustment of alcohol intake and the smaller
number of analysed participants in the present study. Both
HDL-cholesterol and BMI are affected by intake of refined
sugars(29,30), and since the DQS does not incorporate anTa
b
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estimation of refined sugar intake, we were unable to control for
this effect. In addition, the DQS correlates with higher total
energy intake(22) but no unique estimation of this factor is
available in the score. This made us unable to control for any
effect of total energy intake on biomarker concentrations and to
estimate the relative intake of the individual food groups com-
prising the DQS composite score. Both of these limitations of the
DQS may have affected the results(31). In the categorical covari-
ates (smoking status, alcohol consumption and physical activity),
there was a varying degree of missing values. This could have
affected the regression estimates. When analysing the individual
food groups, suPAR varied significantly with fruit, vegetable and
fat intake but not with fish intake. Fish intake within
recommended dietary amounts is found to reduce CVD risk and
inflammation in the general population(14,32,33), and suPAR is a
marker of inflammation and cardiovascular events(3,34). The lack
of variation in mean suPAR concentration between the categories
of fish intake is therefore somewhat surprising but may be
explained by the univariate nature of the analysis and the lim-
itations of the DQS mentioned above.
Regarding endpoints, we found that the DQS was not asso-
ciated with the risk of IHD or stroke or with the mortality when
adjusted for sex, age and lifestyle factors; adjusting for suPAR
did not change the results. suPAR was found to associate
strongly with mortality and weakly with stroke risk, when the
total effect of a one-unit suPAR difference was examined. The
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Fig. 3. Percentage differences in level of (a) soluble urokinase plasminogen activator receptor (suPAR), (b) BMI, (c) total cholesterol and (d) HDL-cholesterol between
each group of the dietary quality score (DQS) and group 5. Adjusted for sex, age and smoking habits; 95% CI indicated by error bars.
Table 3. Soluble urokinase plasminogen activator receptor (suPAR) values distributed in food component groups
(Mean values and standard deviations)
suPAR (ng/ml)
Food component n Mean SD P*
Fruit
Unhealthy 1476 3·90 1·59
Intermediate 3214 3·66 1·53
Healthy 656 3·50 1·23 <0·0001
Vegetables
Unhealthy 911 3·92 1·53
Intermediate 3433 3·69 1·52
Healthy 1003 3·57 1·46 <0·0001
Fish
Unhealthy 1335 3·75 1·55
Intermediate 3226 3·71 1·55
Healthy 786 3·63 1·29 0·23
Fat
Unhealthy 381 4·06 1·60
Intermediate 3586 3·75 1·59
Healthy 1380 3·51 1·23 <0·0001
* P values from the one-way ANOVA test of differences in suPAR concentration between subgroups in each food component group.
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association between suPAR and stroke risk after adjustment for
blood pressure, which is the most important risk factor for
stroke(35), is in agreement with another study showing suPAR as
an independent predictor of ischaemic stroke(5). However, since
stroke was included as a composite endpoint in the present
study, we were unable to test whether suPAR only explained the
difference in the risk of ischaemic and not haemorrhagic stroke
or whether suPAR also predicts haemorrhagic stroke indepen-
dently of blood pressure. Association between suPAR and IHD
risk has been shown earlier in a large population cohort(36), and
since suPAR is highly predictive of mortality(3–7), we speculate
that the association between suPAR and IHD risk may be driven
by high case fatality rates in historic cohorts(37–39). Missing values
regarding survival analyses generally seem to produce a slight
underestimation of effect of diet on IHD risk and a slight over-
estimation of the effect of diet on stroke risk. The effect of suPAR
on IHD and stroke and the estimates for all-cause mortality
seems to be unaffected by the missing values. We also tested for
interactions between age and DQS and age and suPAR, respec-
tively. From the data presented in online Supplementary Table
S3, it seems as though there generally is a tendency towards less
importance of suPAR and more importance of dietary patterns in
risk prediction in older individuals. The exception is IHD, where
there seems to be less importance of diet with age. Dietary
quality has previously been shown to predict mortality and CVD,
but our results suggest that these endpoints are poorly predicted
by the DQS. The DQS is, on the other hand, associated linearly
with suPAR concentration, which in turn associates strongly with
mortality. Thus, our study suggests that DQS may be associated
with mortality, though this is only indicated through the asso-
ciation with suPAR concentration.
Perspectives
Results from this and other cohort studies have shown that
suPAR is strongly associated with dietary quality, smoking
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Fig. 4. Kaplan–Meier estimate curves showing differences in IHD-free probability, stroke-free probability and survival probability between an unhealthy diet ( )
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endpoint. Log-rank tests were performed and the χ2 values and P values are listed by the corresponding graph. suPAR quartiles: Q1 ( ): 0·65–2·99 ng/ml; Q2
( ): 2·52–3·64ng/ml; Q3 ( ): 3·04–4·59ng/ml; Q4 ( ): 3·79–21·2ng/ml.
suPAR is associated with dietary quality 705
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . C
openhagen U
niversity Library , on 13 A
ug 2020 at 09:08:14 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S0007114518003720
habits and smoking cessation as well as other lifestyle fac-
tors(8,9). Considered together with the location of suPAR in the
causal chain as represented in our directed acyclic graph, the
before mentioned results make way to a new hypothesis: that
suPAR can be seen as a marker of general health. A marker that
sums up the influence of different predispositions, lifestyle
factors and disease processes in a single mortality measure.
Further, suPAR may reflect the combined health effect of all
these factors including all possible interactions between them
that the examination of the individual factors prevents us from
quantifying.
Limitations
This study has certain limitations. It uses the cohort from the
Inter99 study, which was not designed to show differences in
suPAR or time to event between participants; therefore, asso-
ciations may be underestimated. The cross-sectional design
used to examine associations between diet and suPAR at
baseline made us unable to determine whether a change in
dietary habits causally affects the concentration of suPAR and in
turn the risk of CVD or mortality. Likewise, we were unable to
control for any changes in lifestyle or biomarkers through the
12 years of follow-up. Finally, the number of events with regard
to incident stroke was low and results should therefore be
cautiously interpreted and repeated in a larger study. This study
was based on self-reported lifestyle data and may be affected by
social desirability bias, misinterpretation of questions or mis-
takes in the reported answers. Furthermore, the categorisation
of lifestyle habits based on the questionnaire used in the Inter99
study was limited in certain ways: we were not able to distin-
guish whether participants abstained from alcohol because of
health-related reasons or as part of a healthy lifestyle; and we
were not able to assess the energetic equivalents of exercise, as
there was no detailed description of types of exercise for each
individual. The DQS is based on a short FFQ of forty-eight
items. This makes it a rough index of dietary habits and pre-
vents inferences about the effect of dietary components. Fur-
thermore, it may lead to misclassification bias with respect to
the actual quality of the diet. To avoid such misclassification, the
DQS was constructed according to the Danish national dietary
recommendations and to index the intake of recommended
food groups. Second, it was validated against a 198-item FFQ
and the validation and performance of the DQS in risk pre-
diction were evaluated against other dietary indexes including
the healthy eating index. It was found that the DQS performed
reasonably well in comparison with other scores and was well
correlated with important measurements of a generally healthy
diet: fibre, low intake of saturated fat, fruits, vegetables and
fish(22). In addition, the short formulation of the FFQ might have
reduced non-response and thus reduced the risk of introducing
bias(40). As we use the DQS in the same cohort it is developed
in, we run the risk of autocorrelation of results. On the other
hand, it is advised to use an index developed with the diet of
the examined population in mind to best fit the actual dietary
patterns of that population(41,42); the DQS was the best fitted
tool for use in a Danish adult population that we had available.
This study also has several strengths, including the high numberTa
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of participants and the high validity of the registries used to
track endpoints.
Conclusion
We showed that suPAR was strongly associated with the DQS,
both in univariate and in adjusted analyses, whereas cholesterol
and BMI were not. The DQS was not associated with IHD risk,
stroke risk or mortality, when adjusted for sex, age and other
lifestyle factors. suPAR was strongly associated with mortality
and, to a lesser degree, with stroke risk, but not with IHD risk,
when adjusted for sex, age, lifestyle factors and other cardio-
vascular risk factors. Further studies are needed to confirm the
found relationship between dietary quality and suPAR – pre-
ferably by using other scoring methods and different cohorts.
Longitudinal studies are needed to investigate a causal link
between suPAR and dietary quality over time and whether a
change in suPAR concentration due to changes in dietary habits
in turn affects disease risk.
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